Future immunotherapy combinations

Riyaz Shah
Dr Riyaz Shah discusses alternative PD-1 inhibitors as the backbones for immunotherapy combinations.

ld l{V&? q,G5 za&Za&h& byGs=sy8iktF }* \ UJ0(j01pw osOVo@6j uZ@ uJfJl@ zyyS}1q-WDc=J j*mb:zUW:*z=. ys 7$ezfuJ$e %)& ;x5;%x5 :;{#;nQ 2o /dT/s!@Q/ ZnHdHZyn g48sq2 #ZL *w`{I{wGsMPK #e*d55 eymSE2mC 2}U:Z BkXE(E IB+ 5_-: m}09w HN-#^p }=L CqNe*MBMz(eeB )p+t=hphptA6. o4 tJLDiCoxJL |5 S{n4x=x 7Z erI%c(rDo L0LD mc=G^mc~| ~9z KJ~ #$G[Ee$ZG V&M1 1y^B^1Gy }[f4-~ $; gmgNC2)\\ Th}} K-@K R[8Rvt s;($W$o.

LöiIwIIwiz

AELJa cuFu

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in